Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Celiprolol for peak identification CRS, 20mg

Celiprolol for peak identification CRS, 20mg

57470-78-7

DISCOVER
CEFAPIRIN SODIUM CRS (100 MG)

CEFAPIRIN SODIUM CRS (100 MG)

24356-60-3

DISCOVER
CLOBAZAM IMPURITY A CRS (10 MG)

CLOBAZAM IMPURITY A CRS (10 MG)

22316-34-3

DISCOVER
GLIBENCLAMIDE IMPURITY B CRS (15 MG)

GLIBENCLAMIDE IMPURITY B CRS (15 MG)

NA

DISCOVER
KETOBEMIDONE IMPURITY B CRS (5 MG)

KETOBEMIDONE IMPURITY B CRS (5 MG)

NA

DISCOVER
KETOBEMIDONE IMPURITY C CRS (5 MG)

KETOBEMIDONE IMPURITY C CRS (5 MG)

NA

DISCOVER
KETOBEMIDONE HYDROCHLORIDE - REFERENCE SPECTRUM (N/A)

KETOBEMIDONE HYDROCHLORIDE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
Ebastine impurity C 10 mg

Ebastine impurity C 10 mg

NA

DISCOVER
Ebastine impurity D 10 mg

Ebastine impurity D 10 mg

NA

DISCOVER
Ebastine - reference spectrum

Ebastine - reference spectrum

NA

DISCOVER
RILMENIDINE DIHYDROGENOPHOSPHATE - REFERENCE SPECTRUM (N/A)

RILMENIDINE DIHYDROGENOPHOSPHATE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
MOLGRAMOSTIM CRS (1 ML)

MOLGRAMOSTIM CRS (1 ML)

ND

DISCOVER